Nordion: Editing the Bribes Out of the Budget

In the Nordion FCPA case, the company agreed to pay a $375,000 civil penalty to settle Securities and Exchange Commission charges over accounting failures that allowed an alleged Russian drug-approval bribery scheme. The SEC said an engineer concealed the intended bribes in revised budgets while collecting personal kickbacks from the agent Nordion paid. For someone who saw an early cost estimate, approved an invoice or questioned a payment destination, the case shows how much can disappear between the original document and the version finance receives.

The SEC announced the settlements on March 3, 2016, covering the company and its former engineer separately for alleged conduct from 2004 through 2011. The Foreign Corrupt Practices Act case follows a liver cancer treatment called TheraSphere, a Russian intermediary and paperwork that allegedly hid what the money was meant to buy.

The Russian Drug-Approval Agent

The Securities and Exchange Commission alleged that Nordion’s engineer arranged for company funds to reach Russian officials through an agent to obtain approval to distribute TheraSphere. According to the engineer’s order, the relationship had begun with a different assignment: finding supplies of cobalt-60. The order describes the agent’s earlier success helping him win the later approval work.

Nordion was a global health science company headquartered in Ottawa, Canada, supplying medical isotopes, targeted therapies and sterilization technologies. The SEC’s order concerning the engineer describes a business accustomed to buying cobalt-60 directly from the Canadian government and selling products directly to health care institutions. According to the order, it had little experience using agents in Russia when the engineer recommended someone he described as a childhood friend who knew the local business landscape.

According to the order, a department manager initially authorized the friend and his company to approach Russian officials informally. The SEC said Nordion later signed a consulting agreement even though the agent had no experience in nuclear power, nuclear medicine or medical isotopes, and the company had performed virtually no due diligence. After the agent helped obtain medical isotopes, Nordion expanded the assignment to registering, licensing and distributing TheraSphere.

That progression matters to third-party due diligence. The SEC’s account describes an employee’s personal recommendation becoming an informal government-facing role, then a written supply assignment, then responsibility for a treatment’s approval. An insider who knows how that relationship grew can explain more than the final consulting contract says.

The False Documentation Behind the Payment

The SEC alleged that the engineer increased budget estimates to hide bribe costs and removed the references that would reveal them. According to the order, the agent’s original estimates separated official government fees from additional charges for influencing the approval process. The engineer allegedly changed those estimates before other Nordion employees reviewed them.

The order describes Russian-language emails setting out costs for each registration and licensing step. The original estimates included “unofficial costs” and additional agent fees to secure favorable acceptance of the treatment. The order quotes the engineer telling the agent:

We see a proposed bribe being edited into a business expense. On the SEC’s account, the engineer changed the description while preserving the funding inside a larger budget. The difference between the drafts exposes both the intended use of the money and the effort to keep that use from other employees.

The alleged concealment continued beyond the estimates. The SEC said the engineer prepared multiple drafts and misrepresented how the agent would use Nordion’s funds. According to the order, Nordion paid invoices that lacked detail and instructed it to send money to offshore accounts belonging to entities the company did not know and that appeared unrelated to the agent.

The payment trail therefore reaches past the consultant’s name on the contract. Here, the original estimate, the revised budget, the invoice and the bank-account instruction described different parts of the same transaction. Comparing them explains how a payment could look routine to one employee while another knew its alleged purpose.

Nordion’s Controls and the SEC Settlement

The Securities and Exchange Commission charged Nordion with books-and-records and internal accounting controls violations. It charged the engineer separately with anti-bribery and false-record violations. The company’s settlement concerned its accounts and controls, while the engineer’s order addressed his alleged authorization of corrupt payments and concealment of the arrangement.

The company traded on the New York Stock Exchange during the conduct described by the SEC. The engineer’s order said his false documentation caused Nordion’s books to misrepresent the payments, and that the company failed to follow its own controls. The specific failures were visible in ordinary business records: an agent retained without meaningful checks, vague invoices and payment instructions naming unfamiliar recipients.

According to the order, Nordion paid approximately $235,043 for the Russian approval work from 2005 through 2011. It ultimately could not distribute TheraSphere in Russia and earned no profits from sales of the product there. We see a particularly lopsided result: Nordion funded the effort and faced a civil penalty, its employee allegedly took a personal cut, and the intended business never materialized.

The SEC’s announcement also credited what Nordion did after discovering evidence of the engineer’s misconduct. The company reported itself, cooperated extensively with the investigation and took immediate remedial steps. The SEC considered that response when setting the settlement terms.

The Engineer’s Kickbacks and Separate Order

The engineer’s order required him to pay back $100,000 in kickbacks. The SEC said bank records showed he received at least that amount from the agent without disclosing it to Nordion. The order also imposed a $66,000 civil penalty.

The SEC alleged that the engineer helped negotiate and monitor the consulting contracts, knew the agent intended to use company money for bribes, and supplied the altered documentation. The order also described U.S.-based email accounts, meetings with the agent in the United States and transfers through U.S. correspondent bank accounts. The alleged kickback gave the engineer a personal interest in the costs he helped justify. A colleague who knew only the registration work would see a different transaction from someone who knew the agent was paying him.

When Healthcare Payments Survive the Review

Government decisions can determine whether a healthcare product reaches a market and which products public hospitals buy. In pharmaceutical-industry remarks in 2015, the SEC’s enforcement director described public-hospital doctors, pharmacists and administrators as decision-makers who can qualify as foreign officials. The remarks also identified licensing and inspection officials among the government contacts that pharmaceutical businesses encounter.

Nordion’s alleged scheme targeted permission to distribute a treatment. Other health care cases show how the concealment can continue after payments reach the books. In its separate order concerning Fresenius Medical Care, the SEC described employees cashing checks and handing the money to a manager, with transactions falsely recorded as project marketing expenses and collection commissions.

The Fresenius order also described efforts to conceal the misuse of funds from investigators:

The 2022 Journal of Forensic and Investigative Accounting paper Fresenius Medical Care: A Case Study on the FCPA concluded that managers and employees circumvented controls and continued bribe payments despite flagged transactions and policies. In Nordion’s case, the engineer allegedly removed the telling language before his colleagues reviewed the budget, leaving the reviewers with a document already stripped of the payment’s purpose.

What an Insider Would Recognize

An insider’s knowledge can connect the official decision, the payment and the false record. The SEC’s allegations against Nordion’s engineer make that connection concrete: a registration assignment became a budget, the budget concealed an intended bribe, and the company’s payment reached an agent who allegedly compensated its employee.

Someone involved in regulatory work may understand which approval the agent was engaged to obtain. A colleague who saw earlier drafts may know what changed before review. A finance employee may recognize the mismatch between the contracted consultant and the account named for payment. Those are different views of the same whistleblower evidence, and we work with you to connect them.

For foreign-bribery information, we assess the SEC whistleblower award framework against the conduct and your contribution. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. That is a different program from the SEC’s, and we work out with you which one fits what you know.

You Know What the Budget Left Out

If you saw approval costs rewritten, an agent paid through unfamiliar accounts or an employee taking a hidden cut, talk with our whistleblower experts about the transaction you know. We connect that inside knowledge to the payment evidence, bring in FCPA whistleblower lawyers who understand overseas agents and public-company accounting, and stand with you as we build your strongest FCPA whistleblower case.